F. Hoffmann-La Roche Ltd, Atlas Medical, and Sentinel Ch. SpA, among others, are the major players in the COVID-19 diagnostics market in the Middle East and Africa.
As per the analysis by Expert Market Research, the Middle East and Africa COVID-19 diagnostics market is being aided by the growing number of COVID-19 patients, which has reached over 2.76 million people within the MENA region as per November 2020.
The laboratories segment contributes a major share in the COVID-19 diagnostics industry. Due to the constant increase in the laboratory capacity by the expansion of testing portfolios and the creation of modern laboratories, the usage of detection kits is maximised. It is expected that the cases in South Africa are going to increase, which in return, would boost the Middle East and Africa COVID-19 diagnostics market. The emergence of the modern testing technologies will also result in the growth of the diagnostics industry.
The centralised approach that works towards the production of kits and apps, and monitoring programmes for mass testing offers information on symptoms and risks. The adoption of the drive-through and walk-through testing centres for the expansion of testing sites is further expected to drive the regional market growth.
The SAR-CoV-2 antigen self-test nasal for home, which enables people to simply test themselves for COVID-19 at home with a straightforward nose swab, got a CE mark, according to an announcement made by Roche in June 2021. Through a special QR Code, their digital solution enables them to instantly store, display, and share their test findings. They also launched a variant test which helps to monitor the emerging mutations of coronavirus.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
F. Hoffmann-La Roche is the world’s number one biotech company with seventeen pharmaceuticals in the market. The company is committed to improving lives by creating innovative medicines and diagnostic tests globally. It is one of the first companies to bring required treatments to patients. Two-thirds of their research and development projects are with companion diagnostics. Their diagnostic areas of interest include diabetes, tissue/haematology/urine diagnostics and coagulation testing.
The company has a focus to advocate, educate, and train the healthcare community on its medical technologies. Atlas Medical has three divisions: medical, pharmaceutical, and hospital infrastructure. They have expertise in radiology, cardiology, neurology, dental, gynaecology, dermatology, and many more medical departments. The company also provides services in diagnostics and has therapeutic and laboratory equipment. The pharmaceutical branch is responsible for importing, marketing, sales, and distribution of pharmaceutical products.
Sentinal Diagnostics is involved in developing and producing in-vitro diagnostics. They are the first IVD manufacturer in Italy and provide high-quality and reliable IVD products for clinical diagnosis. The company is engaged in three areas of activity: Molecular diagnostics, Fecal Immunochemical Testing, and Clinical Chemistry & Immunochemistry. Molecular diagnostics has expanded its tests; it now includes a virology panel which contains tests for the detection of SARS-CoV-2. They also invest in research and development of laboratory tests and product improvement.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.